ConductScience.org, home

Paper29099271

SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.

Feng C and 10 others. Cell Cycle, 2018. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell. Papers, record 29099271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29099271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.
PubMed
Journal
Cell Cycle
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2020-09-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feng CChenzhe
2Ma FFang
3Hu CChunhong
4Ma JAJin-An
5Wang JJingjing
6Zhang YYang
7Wu FFang
8Hou TTao
9Jiang SShun
10Wang YYapeng
11Feng YYeqianhttps://orcid.org/0000-0001-7964-6784

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cation Transport ProteinsMajor topic
CisplatinMajor topic
Drug Resistance, NeoplasmMajor topic
MicroRNAsMajor topic
SOX9 Transcription FactorMajor topic
3' Untranslated Regions
Antagomirs
Apoptosis
Cell Line, Tumor
Copper Transporter 1
Female
HeLa Cells
Humans
PTEN Phosphohydrolase
Promoter Regions, Genetic
Protein Binding
RNA Interference
RNA, Small Interfering
Signal Transduction
Uterine Cervical Neoplasms

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127354763Molecular mechanisms of cisplatin resistance in cervical cancer.Drug Des Devel Ther2016https://conductscience.org/library/papers/27354763PubMed
220541702Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.Cancer Cell2010https://conductscience.org/library/papers/20541702PubMed
326131930Directional dominance on stature and cognition in diverse human populations.Nature2015https://conductscience.org/library/papers/26131930PubMed
422052544Sox9 is upstream of microRNA-140 in cartilage.Appl Biochem Biotechnol2012https://conductscience.org/library/papers/22052544PubMed
523137650Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.Exp Cell Res2013https://conductscience.org/library/papers/23137650PubMed
62551577Testicular cancer.Curr Probl Cancer1989https://conductscience.org/library/papers/2551577PubMed
722624711Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Cancer Cell2012https://conductscience.org/library/papers/22624711PubMed
86370067Drugs five years later. Cisplatin.Ann Intern Med1984https://conductscience.org/library/papers/6370067PubMed
922725681Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients.Clin Exp Pharmacol Physiol2012https://conductscience.org/library/papers/22725681PubMed
1021489289The functional role of long non-coding RNA in human carcinomas.Mol Cancer2011https://conductscience.org/library/papers/21489289PubMed
1127973410Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.Int J Mol Sci2016https://conductscience.org/library/papers/27973410PubMed
1228273813Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Genes (Basel)2017https://conductscience.org/library/papers/28273813PubMed
1326878385mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.Expert Opin Ther Targets2016https://conductscience.org/library/papers/26878385PubMed
1426885752SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.Oncotarget2016https://conductscience.org/library/papers/26885752PubMed
1524403515Membrane transporters as mediators of cisplatin side-effects.Anticancer Res2014https://conductscience.org/library/papers/24403515PubMed
1627040383Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.Arch Biochem Biophys2016https://conductscience.org/library/papers/27040383PubMed
1721823020TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro.J Huazhong Univ Sci Technolog Med Sci2011https://conductscience.org/library/papers/21823020PubMed
1826115978The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.Gynecol Oncol2016https://conductscience.org/library/papers/26115978PubMed
1925491626The role of raltitrexed/cisplatin with concurrent radiation therapy in treating advanced cervical cancer.Eur Rev Med Pharmacol Sci2014https://conductscience.org/library/papers/25491626PubMed
2024874729Systems biology of cisplatin resistance: past, present and future.Cell Death Dis2014https://conductscience.org/library/papers/24874729PubMed

See all 36 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42766055Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets.Daru2026https://conductscience.org/library/papers/42766055PubMed
40583066Pattern of SOX9 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma, and matrix-producing metaplastic carcinoma of the breast lends support to common biology.Virchows Arch2025https://conductscience.org/library/papers/40583066PubMed
40392306The SOX gene superfamily in oncogenesis: unraveling links to ncRNAs, key pathways, chemoresistance, and gene editing approaches.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40392306PubMed
39659361Novel insights into cuproptosis inducers and inhibitors.Front Mol Biosci2024https://conductscience.org/library/papers/39659361PubMed
39544714Role of SLC31A1 in prognosis and immune infiltration in breast cancer: a novel insight.Int J Clin Exp Pathol2024https://conductscience.org/library/papers/39544714PubMed
39448672Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer.Sci Rep2024https://conductscience.org/library/papers/39448672PubMed
39337406Micro- and Macronutrients in Endometrial Cancer-From Metallomic Analysis to Improvements in Treatment Strategies.Int J Mol Sci2024https://conductscience.org/library/papers/39337406PubMed
39263322Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses.Front Cell Dev Biol2024https://conductscience.org/library/papers/39263322PubMed
37107173SDNOR, a Novel Antioxidative lncRNA, Is Essential for Maintaining the Normal State and Function of Porcine Follicular Granulosa Cells.Antioxidants (Basel)2023https://conductscience.org/library/papers/37107173PubMed
36995552NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.Funct Integr Genomics2023https://conductscience.org/library/papers/36995552PubMed
36984544Ovarian Cancer-Insights into Platinum Resistance and Overcoming It.Medicina (Kaunas)2023https://conductscience.org/library/papers/36984544PubMed
36776364p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma.Front Oncol2022https://conductscience.org/library/papers/36776364PubMed
36003340Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches.Front Genet2022https://conductscience.org/library/papers/36003340PubMed
35138470SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition.Biochem Genet2022https://conductscience.org/library/papers/35138470PubMed
35113247Molecular mechanisms associated with chemoresistance in esophageal cancer.Cell Mol Life Sci2022https://conductscience.org/library/papers/35113247PubMed
35083143The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin.Front Oncol2021https://conductscience.org/library/papers/35083143PubMed
34881182SOX9: Advances in Gynecological Malignancies.Front Oncol2021https://conductscience.org/library/papers/34881182PubMed
34453645Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.Mol Cell Biochem2021https://conductscience.org/library/papers/34453645PubMed
33926008PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.Cancers (Basel)2021https://conductscience.org/library/papers/33926008PubMed
33868274Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.Front Immunol2021https://conductscience.org/library/papers/33868274PubMed

See all 33 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MIR130A406919PubTator's text mininghttps://conductscience.org/library/genes/406919NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
SLC31A11317PubTator's text mininghttps://conductscience.org/library/genes/1317NCBI Gene
SOX96662PubTator's text mininghttps://conductscience.org/library/genes/6662NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29099271

GET https://conductscience.org/api/papers/v1/29099271/references?page=2